<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00870077</url>
  </required_header>
  <id_info>
    <org_study_id>Protobese</org_study_id>
    <nct_id>NCT00870077</nct_id>
  </id_info>
  <brief_title>A Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver Disease</brief_title>
  <acronym>PROTOB</acronym>
  <official_title>Effect of a Whey Protein Supplementation on Intrahepatic Lipids in Obese Patients With Non-alcoholic Fatty Liver Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Lausanne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An increase in dietary protein intake has been shown to blunt the increase in intrahepatic
      fat induced by high fat feeding in healthy individuals. The purpose of this study is to
      determine if a protein supplementation decreases intrahepatic fat in obese patients with
      non-alcoholic fatty liver disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      12 obese patients will be be treated with a dietary whey protein supplementation over 4
      weeks. Their intrahepatic fat content, glucose tolerance, and body weight will be evaluated
      before and after 4 weeks of supplementation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intrahepatic fat</measure>
    <time_frame>before and after 4 weeks of whey protein supplementation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>glucose metabolism</measure>
    <time_frame>4-hour oral glucose tolerance test with indirect calorimetry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body weight and body fat</measure>
    <time_frame>before and after 4 weeks whey protein supplementation</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Non-alcoholic Fatty Liver Disease</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>ProWHEY 94 CFM, SponserR</intervention_name>
    <description>3 times 20g per day</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI higher than 35 kg/m2

          -  age 18-50 years

          -  sex male or female

          -  ASAT/ALAT &gt; 1.8

        Exclusion Criteria:

          -  treatment with hypolemic or antidiabetic agents

          -  blood glucose &gt; 7 mmol/l

          -  alcohol intake &gt; 20g/day

          -  creatinin &gt; 120 umol/l)

          -  contra-indications to Magnetic resonnance imaging
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luc Tappy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire Vaudois</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre d'investigations cliniques &quot;cardiomet&quot;/ CHUV</name>
      <address>
        <city>Lausanne</city>
        <state>VD</state>
        <zip>CH-1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2009</study_first_submitted>
  <study_first_submitted_qc>March 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2009</study_first_posted>
  <last_update_submitted>February 23, 2012</last_update_submitted>
  <last_update_submitted_qc>February 23, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 24, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne</investigator_affiliation>
    <investigator_full_name>Luc Tappy, MD</investigator_full_name>
    <investigator_title>professor of physiology</investigator_title>
  </responsible_party>
  <keyword>Intrahepatic fat</keyword>
  <keyword>obesity</keyword>
  <keyword>body fat</keyword>
  <keyword>impaired glucose tolerance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

